The FDA has approved Orlynvah, a new oral treatment for uncomplicated urinary tract infections (UTIs) in women who have limited options for effective antibiotic therapy.

You may have heard about — or maybe even experienced — the short-term side effects of Ozempic® — such as nausea, vomiting, ...

The label also alerts patients that the drug is associated with urinary retention ... Bristol Myers Squibb is continuing to study the drug for its longer term effects, as well as to understand and ...

Prescriptions not filled through legitimate channels may not be FDA approved, may have inaccurate labeling on the packaging, and may have ineffective or potentially harmful ingredients.

Atorvastatin is a prescription drug used for lowering cholesterol and triglyceride levels and reducing certain heart-related ...

Dr Fares Qeadan, the paper’s primary author, explains to Popular Science that opioids and alcohol were chosen for the study because “both … interact with reward pathways in the brain that GLP-1 ...

Basel, October 29, 2024 – Novartis announced today that Scemblix ® (asciminib) was granted accelerated approval by the US Food and Drug Administration (FDA) for adult patients with newly diagnosed ...

Postmarketing requirement fulfilled based on data demonstrating QYSMIA® reduces blood pressure -CAMPBELL, Calif., Oct. 28, 2024 (GLOBE ...

This is the ending everyone prayed would not happen, but worried would come to pass,” a music industry source told Page Six.

The approval of this new label reflects the positive outcome of our ongoing and productive dialogue with the FDA, which shares our commitment to addressing unmet medical ... For more information ...

UCB submitted a supplemental biologics license application for bimekuzimab (Bimzelyx) to the FDA in April for the drug’s approval in moderate to severe hidradenitis suppurativa (HS).